Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Vaccines
Sort By
Newest First
1 / 8
1 / 8
dbDNA
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
Jill Makin
Touchlight
PAO-08-24-CL-01
Aug 19, 2024
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07
Nov 09, 2023
Inhalation Vaccines
The Exciting Potential of Inhalation Vaccines
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-11-022-NI-10
Nov 15, 2022
Intranasal Vaccines
Increasing Safety, Efficacy, and Global Equity with Intranasal Vaccines
Chad Costley, M.D.
BlueWillow Biologics
PAO-04-022-CL-15
Apr 28, 2022
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
lrike Fiedler Dr. Rer. Nat.
IDT Biologika
PAO-04-022-CL-02
Apr 13, 2022
GMP
Intravacc Announces the Publication of a GMP Process for a Semi-Synthetic Shigella Glycoconjugate Vaccine Candidate from Institut Pasteur
Intravacc
PR-M03-22-09
Mar 22, 2022
License Agreement
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China
Nuance Pharma
PR-M03-22-08
Mar 21, 2022
Alzheimer's Vaccine
Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's
Araclon Biotech
PR-M03-22-06
Mar 15, 2022
Animal Vaccines
World-Class Solutions for Livestock Vaccines
Medgene Labs
PAO-03-22-R250-09
Mar 14, 2022
Scale-Up Collaboration
IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines
IDT Biologika
PR-M03-22-01
Mar 01, 2022
CDMO Acquisition
Vibalogics Acquired by Top Global CDMO Recipharm AB
Vibalogics
PR-M02-22-18
Feb 18, 2022
License Agreement
Confirmation That the License to Develop Oral Vaccine Delivery Platform Has Been Executed
Poolbeg Pharma PLC
PR-M01-22-22
Jan 31, 2022
Vaccines
100 Years in Vaccines and Looking Toward the Future
IDT Biologika
PAO-01-22-R250-13
Jan 28, 2022
Vaccines
IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities
IDT Biologika
PR-M01-22-13
Jan 20, 2022
Viral Vaccines
Viral Vectors, Vaccines — A New Era Of Collaborative Design
Andreas Neubert, Ph.D.
IDT Biologika
PAO-10-21-CL-17
Nov 08, 2021
Vaccines
IDT Biologika Celebrates 100 Years of Successful Vaccine Development and U.S. Expansion
Ashik Pavagadhi
IDT Biologika
PAO-10-21-CL-07-793
Oct 15, 2021
Partnership
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™
PR-M06-21-024
Jun 18, 2021
Genetic Vaccines
Working to Overcome Analytical Challenges Posed by Genetic Vaccines
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-21-NI-01
Jun 04, 2021
Vaccine
Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response
Vaxxas
PR-M06-21-006
Jun 04, 2021
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
Samsung Biologics
PR-M05-21-016
May 25, 2021
